Catalyst Wire Dossier Catalyst Wire Dossier

Repso

leflunomide · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Repso, covering 2016-04-21 to 2016-04-21. Get the full timeline:

Most recent: EMA Withdrawn: Repso (leflunomide) — Teva B.V.

See pricing